NM4.F Natus Medical Incorporated
- Market cap
- EUR 9.70M
- P/E
- -
- P/B
- 21.28x
- ROE
- -1,005.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is NM4.F undervalued?
Graham numberThe Graham number of Natus Medical Incorporated cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Natus Medical Incorporated fundamental analysis
No fundamental analysis for Natus Medical Incorporated yet.
Natus Medical Incorporated stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company offers valve services; sales, service, construction steam boilers, steam systems, and sales of fittings, such as heat exchangers, steam traps, control valves and condensate pumps; grinding materials, training, machinery and service; battery storage and frequency regulation, commissioning and s…
Full company profileNatus Medical Incorporated financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Natus Medical Incorporated annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 382M | 501M | 531M | 495M | 416M | 473M | 225M | 342M | 324M | 313M | 317M |
| Gross Profit | 235M | 281M | 304M | 292M | 217M | 274M | 167M | 234M | 254M | 218M | 212M |
| Operating Income | 56.8M | 9.63M | 12.7M | 29.1M | -16.4M | 31.5M | -13.2M | 1.69M | -79.5M | -65.0M | -41.4M |
| EBITDA | - | 40.3M | 8.40M | 14.4M | 9.71M | 49.3M | -8.59M | 29.1M | -14.9M | -37.7M | -19.1M |
| Net Income | 42.6M | -20.3M | -22.9M | -15.7M | -16.6M | 13.2M | -34.2M | -4.26M | -76.9M | -102M | -50.1M |
| EPS | - | -0.61 | -0.68 | -0.46 | -0.49 | 0.39 | -1.76 | -0.19 | -3.22 | -3.83 | -1.05 |
| Balance Sheet | |||||||||||
| Total Assets | 649M | 710M | 638M | 623M | 600M | 564M | 196M | 339M | 264M | 259M | 222M |
| Total Liabilities | 232M | 288M | 240M | 206M | 189M | 140M | 139M | 252M | 246M | 223M | 217M |
| Shareholders' Equity | 417M | 422M | 398M | 416M | 411M | 425M | 56.8M | 78.7M | 17.7M | 36.1M | 4.98M |
| Cash & Short-term Investments | 214M | 89.0M | 56.4M | 63.3M | 82.1M | 75.6M | 13.3M | 30.3M | 12.1M | 37.5M | 20.0M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 72.7M | 19.7M | 33.0M | 60.1M | 34.4M | 64.0M | 8.26M | 8.34M | 1.47M | -20.2M | -66.3M |
| Capital Expenditure | 3.40M | 4.07M | 7.88M | 5.33M | 8.61M | 3.62M | 9.51M | 8.19M | 9.60M | 7.80M | 0.00 |
| Free Cash Flow | - | 15.7M | 24.5M | 54.7M | 25.8M | 60.4M | -1.25M | 152K | -8.13M | -28.0M | -66.3M |
| Ratios | |||||||||||
| ROE | 10.2% | -4.8% | -5.8% | -3.8% | -4.0% | 3.1% | -60.2% | -5.4% | -433.6% | -281.5% | -1,005.9% |
| ROA | 6.6% | -2.9% | -3.6% | -2.5% | -2.8% | 2.3% | -17.4% | -1.3% | -29.2% | -39.2% | -22.6% |
| Net Profit Margin | 11.2% | -4.1% | -4.3% | -3.2% | -4.0% | 2.8% | -15.2% | -1.2% | -23.8% | -32.4% | -15.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Natus Medical Incorporated dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | SEK 6.79M | 0.35 | - |
| 2021 | USD 91.0M | 2.66 | 690.4% |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Natus Medical Incorporated
- Insiders 52.35%
- Institutions 34.43%
- Public & others 13.23%
- Shares outstanding 47.6M
- Free float 25.6M
Natus Medical Incorporated company profile
- Company name
- Natus Medical Incorporated
- Ticker
- NM4.F
- ISIN
- SE0007439633
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 170
- Fiscal year end
- December
- Address
- Kammakargatan 7, Stockholm, Sweden, 111 40
- Phone
- 608 829 8500
- Website
- vimabgroup.com
About Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company offers valve services; sales, service, construction steam boilers, steam systems, and sales of fittings, such as heat exchangers, steam traps, control valves and condensate pumps; grinding materials, training, machinery and service; battery storage and frequency regulation, commissioning and service; manufactures, develops and leases; services and products for industrial applications; mechanical workshop and DIY manufacturer for companies in a variety of industries; and CNC milling, CNC turning, cutting and spare parts manufacturing of components. It also provides sales, service, design and manufacture of electric steam boilers, steam systems as well as sales of fixtures, heat exchangers, steam traps, control valves, and condensate pumps; molds, tooling, prototypes, rollers, shafts, and many other machine components. In addition, the company operates repair and energy-producing industries, and builds various infrastructure networks, such as fiber and power supply; and personnel supply for industry and software development. Vimab Group AB (publ) was incorporated in 2011 and is based in Stockholm, Sweden.
Natus Medical Incorporated management
5- Mr. Peter FredellCEO & Director · born 1965
- Ms. Anna BondeChief Financial Officer · born 1977
- Markus AngleredDeputy CEO & COO · born 1976
- Rickard NybergTechnical Manager · born 1979
- Jockum NilssonC. I. O · born 1975